News

EIT Launches call for STEM education initiatives

Published on | 2 weeks ago

Programmes EIT

The EIT Higher Education Initiative's new call is designed to strengthen the innovation capacity and entrepreneurship within the STEM fields. By 2028, the initiative aims to impact 200,000 students, academics, and non-academic staff through training in innovation, entrepreneurship, and intellectual property management. A total budget of €70 million is allocated for this call, allowing up to €2 million per project over a 24-month period from 2026 to 2028.

The application deadline is set for 4 March 2026 at 17:00 CET. The first information sessions is scheduled for 15 December 2025 to offer further guidance on project priorities and collaboration opportunities. More details about the call can be found on the EIT website.

 

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1772 articles available search in articles 

Testimonial

image of BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.